Publication | Closed Access

Influence of the angiotensin converting enzyme inhibitor ramipril on high-sensitivity C-reactive protein (hs-CRP) in patients with documented atherosclerosis

InflammationThrombosisHypertensionVascular DiseaseEnzyme Inhibitor RamiprilDocumented AtherosclerosisCardiovascular DiseasePharmacologyVascular BiologyDyslipidemiaArterial DiseaseHigh-sensitivity C-reactive ProteinPublic HealthMedicineAtherosclerosisEpidemiology